Holen Sie sich die Stockscreener-App
1.56
0.64%
-0.01
Schlusskurs vom Vortag:
$1.57
Offen:
$1.58
24-Stunden-Volumen:
1.40M
Relative Volume:
0.42
Marktkapitalisierung:
$1.16B
Einnahmen:
$581.12M
Nettoeinkommen (Verlust:
$-212.92M
KGV:
-5.6976
EPS:
-0.2738
Netto-Cashflow:
$-174.22M
1W Leistung:
-4.88%
1M Leistung:
-7.69%
6M Leistung:
+36.84%
1J Leistung:
+1.30%
1-Tages-Spanne:
$1.55
$1.58
1-Wochen-Bereich:
$1.55
$1.65
52-Wochen-Spanne:
$0.9769
$1.75
Opko Health Inc Stock (OPK) Company Profile
Firmenname
Opko Health Inc
Sektor
Branche
Telefon
305-575-4181
Adresse
4400 BISCAYNE BLVD., MIAMI, FL
Compare OPK vs TMO, DHR, NTRA, A, IQV
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OPK
Opko Health Inc
|
1.56 | 1.22B | 581.12M | -212.92M | -174.22M | -0.2738 |
TMO
Thermo Fisher Scientific Inc
|
654.80 | 241.26B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
214.06 | 157.81B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
410.35 | 59.47B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
167.78 | 48.71B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
258.21 | 44.50B | 16.63B | 1.39B | 2.12B | 8.0674 |
Opko Health Inc Stock (OPK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-20 | Eingeleitet | JP Morgan | Neutral |
| 2025-10-31 | Herabstufung | Jefferies | Buy → Hold |
| 2025-04-25 | Eingeleitet | JP Morgan | Neutral |
| 2023-06-29 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2022-12-15 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-01-24 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2021-06-21 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2019-11-25 | Eingeleitet | Piper Jaffray | Overweight |
| 2018-03-02 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2017-09-14 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2016-06-21 | Bestätigt | Standpoint Research | Buy |
| 2016-06-03 | Eingeleitet | Standpoint Research | Buy |
| 2016-03-31 | Bestätigt | Barrington Research | Outperform |
| 2015-10-16 | Eingeleitet | JP Morgan | Overweight |
| 2015-09-11 | Herabstufung | Jefferies | Buy → Hold |
| 2015-03-03 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2014-05-12 | Bestätigt | Oppenheimer | Outperform |
| 2014-03-14 | Eingeleitet | Oppenheimer | Outperform |
| 2013-11-13 | Bestätigt | Ladenburg Thalmann | Buy |
| 2013-05-30 | Bestätigt | Ladenburg Thalmann | Buy |
| 2012-10-22 | Eingeleitet | Barrington Research | Outperform |
| 2011-12-01 | Bestätigt | Ladenburg Thalmann | Buy |
| 2011-07-14 | Eingeleitet | Ladenburg Thalmann | Buy |
Alle ansehen
Opko Health Inc Aktie (OPK) Neueste Nachrichten
OPKO Health (NASDAQ:OPK) Stock Rating Upgraded by Zacks Research - MarketBeat
OPK4048118 Bond Profile: Coupon and Redemption - TradingView
OPKO Health, Inc. (OPK) stock price, news, quote and history - uk.finance.yahoo.com
Here's Why You Should Retain OPK Stock in Your Portfolio for Now - TradingView
OPK5991654 Bond Profile: Coupon and Redemption - TradingView
Promising Penny Stocks To Watch In September 2026 - simplywall.st
OPKO Health, Inc. (OPK) Stock Price, News, Quote & History - Yahoo! Finance Canada
OPKO Health (NASDAQ:OPK) Reaches New 12-Month HighShould You Buy? - MarketBeat
Opko Health stock hits 52-week high at 1.74 USD By Investing.com - Investing.com Australia
Opko Health stock hits 52-week high at 1.74 USD - Investing.com
OPKO Health, Inc. (OPK) latest stock news and headlines - Yahoo Finance Singapore
OPK Stock Climbs 32.5% YTD: What's Driving the Rally in 2026? - Zacks Investment Research
OPKO Health stock gains support from improved Q2 2026 results - AD HOC NEWS
OPKO Health (NASDAQ:OPK) Shares Pass Above 50-Day Moving AverageShould You Sell? - MarketBeat
The Bull Case For OPKO Health (OPK) Could Change Following New Mazdutide Royalty-Backed Financing Strategy - Yahoo Finance
OPKO Health (OPK) Cashes In A Future Royalty Stream Early - Yahoo Finance
OPKO Health (OPK) Stock Looks Rich As Cash Flow Risks Cloud Fair Value - webull.com
OPKO Health Pivots to Therapeutics, Eyes Data-Rich 12 to 18 Months - Yahoo Finance
OPKO Health at Wells Fargo conference: cash-rich pivot to therapeutics - Investing.com Canada
Bank of New York Mellon Corp Takes Position in OPKO Health, Inc. $OPK - MarketBeat
OPKO Health to Participate in the Wells Fargo 21st Annual Healthcare Conference - The Manila Times
A healthcare conference will feature two OPKO executives on Sept. 10 - Stock Titan
OPKO Health, Inc. (NASDAQ:OPK) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Steris (STE) Down 2.1% Since Last Earnings Report: Can It Rebound? - Zacks Investment Research
OPKO Health, Inc. Revenue Breakdown – TRADEGATE:XCY - TradingView
OPK - Finviz
OPKO Health (NASDAQ:OPK) Sets New 1-Year HighHere's Why - MarketBeat
OPKO Health (NASDAQ:OPK) Trading Up 8.2%Here's Why - MarketBeat
Opko Health Inc (OPK) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
BlackRock Inc. Takes Position in OPKO Health, Inc. $OPK - MarketBeat
OPKO Health (OPK) Slips 1.33% to $1.48 as Shares Consolidate Between Support and ResistanceFactor Timing - dars.gov.et
OPK Q2 2026 Earnings: Narrower-Than-Expected Loss Drives 87.6% EPS SurpriseEarnings Per Share - careplusvn.com
Income Statement - OPKO Health, Inc.
Opko Health Inc (OPK) Peer Comparison – Compare with Others - valueresearchonline.com
Why Is OPKO Health (OPK) Down 9.7% Since Last Earnings Report? - Yahoo Finance
COCP: 5 Million Private Placement with OPKO Health - Smartkarma
COCP: $5 Million Private Placement with OPKO Health - Yahoo Finance
Is OPK Worth Buying as Valuation Meets Improving Business Trends? - Zacks Investment Research
OPK Raises $125 Million Against Royalties: What Investors Should Know - Eastern Progress
OPK Climbs 12.4% in the Past Month: Can the Stock Rally Keep Going? - TradingView
Zacks Research Has Positive View of OPKO Health Q3 Earnings - MarketBeat
OPKO (OPK) Latest Results Brief: EPS Prints Above Forecast in the Latest Reading; Shares After the Report: The Market Reaction Is MutedTrough Earnings Signal - Vinanet
OPKO Health Secures $125 Million Financing Against Mazdutide Royalties - TradingView
Should OPKO Health’s Royalty-Backed US$125 Million Financing Shift Matter to OPKO Health (OPK) Investors? - Sahm
OPKO Health (OPK) Retreats to $1.38 as Support at $1.31 Comes into FocusMomentum Surge Alerts - vinanet.vn
OPKO Health (OPK) Raises $125 Million, Is The Upside Already Priced In? - Sahm
OPKO Health Raises $125 Million in Senior Secured Debt Financing - Minichart
OPKO Health (OPK) Slips to $1.38, Pressing Key Support at $1.31ATR Trailing Stop - vinanet.vn
OPKO Health Raises $125M Through Senior Secured Notes Backed by Mazdutide Royalties - Kalkine Media
OPKO Health Raises $125 Million in Additional Royalty-Backed Notes Under Amended HCR Agreement - TradingView
OPKO Health (NASDAQ:OPK) Trading Down 5.4%Here's What Happened - MarketBeat
Finanzdaten der Opko Health Inc-Aktie (OPK)
Umsatz
Nettogewinn
Free Cashflow
ENV
Opko Health Inc-Aktie (OPK) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| FROST PHILLIP MD ET AL | CEO & Chairman |
Nov 21 '25 |
Buy |
1.33 |
580,000 |
768,807 |
216,706,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Nov 20 '25 |
Buy |
1.33 |
580,000 |
771,328 |
216,126,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Nov 19 '25 |
Buy |
1.31 |
580,000 |
759,115 |
215,546,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Nov 18 '25 |
Buy |
1.27 |
533,300 |
678,906 |
214,966,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Oct 31 '25 |
Buy |
1.42 |
150,000 |
213,435 |
214,386,448 |
0.97%
0.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):